Logo Image
News
Media
Between the LinesExpert InterviewsK-CastMedical World NewsPodcastsPopulation Health PerspectivesShorts
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
HSE SummitWebinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory
Commentaries

Subscribe

  • News
  • Media
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Commentaries
  • Subscribe
  • ADHD
  • Acute Pain
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Metabolic Dysfunction-Associated Steatohepatitis
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type 2 Diabetes
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
AIDS 2026|
PBMI Innovators|
2026 State of Pharmacy survey results available now|
ASRS 2026|
Our July 2026 issue
Advertisement

Tom Martin, M.A., MBA

Advertisement
Tom Martin, M.A., MBA

Tom Martin, M.A., MBA, is vice president, client relations, DRG Claims Management

Articles by Tom Martin, M.A., MBA

CMS’ RADV Strategy Will Reverberate Throughout Health Plan Operations

ByEric Levine, M.P.H.,Tom Martin, M.A., MBA,Mark Newsom, M.Sc.,Kirsten Stryker Blasch
June 30th 2025

To prepare for CMS’ new risk adjustment data validation (RADV) strategy, Medicare Advantage plans must take a coordinated, organization-wide approach.

What a Nonpayment Integrity SME Needs to Know About Payment Integrity

ByTom Martin, M.A., MBA
June 4th 2025
AI written on brain floating over circuitry imagery | Image credit : ©fanjianhua stock.adobe.com

Embracing AI Wisely: A Health Plan Leader’s Guide to Benefits, Risks, and Readiness

ByTom Martin, M.A., MBA,Eric Levine, M.P.H.,Viju Shamana
May 7th 2025

The authors provide a detailed framework for assessing the adoption of artificial intelligence.

Advertisement

Latest Updated Articles

  • CMS’ RADV Strategy Will Reverberate Throughout Health Plan Operations
    CMS’ RADV Strategy Will Reverberate Throughout Health Plan Operations

    June 30th 2025



Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

500,000 Medicaid beneficiaries with diabetes to lose coverage by 2034

2

Ashley Holzworth-Nash, Pharm.D., Evernorth

3

New cholesterol guideline expands treatment eligibility to 55% of U.S. adults

4

Medicaid work requirements and how states may apply them: An in-depth discussion with Eric Levine, M.P.H., of Avalere Health

5

Adalimumab grabs top spot as most cost-efficient biologic for hidradenitis suppurativa

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us